ISLET Act

Hozzl · 2024-02-05T14:30:09Z

Explore the details of House Bill 4304 ISLET Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

2/5/2024, 2:30 PM

Summary of Bill HR 4304

The ISLET Act, also known as Bill 118 hr 4304, is a piece of legislation currently being considered by the US Congress. The purpose of this bill is to provide funding and support for research into the treatment and potential cure for type 1 diabetes.

The ISLET Act aims to allocate resources towards the study of islet cell transplantation, a promising treatment for type 1 diabetes. Islet cells are responsible for producing insulin in the body, and transplanting healthy islet cells into individuals with type 1 diabetes can help regulate their blood sugar levels.

The bill proposes funding for research institutions and medical centers to further study islet cell transplantation and its effectiveness in treating type 1 diabetes. It also calls for the establishment of a national registry to track outcomes of islet cell transplants and improve patient care. Overall, the ISLET Act seeks to advance research and innovation in the field of diabetes treatment, with the ultimate goal of improving the quality of life for individuals living with type 1 diabetes.

Current Status of Bill HR 4304

Bill HR 4304 is currently in the status of Bill Introduced since June 22, 2023. Bill HR 4304 was introduced during Congress 118 and was introduced to the House on June 22, 2023. Bill HR 4304's most recent activity was Referred to the Subcommittee on Health. as of June 23, 2023